Showing 1 - 6 results of 6 for search 'Robert S Pedersen', query time: 0.05s Refine Results
  1. 1
    P817: VALIDATION OF THE SECOND REVISED INTERNATIONAL STAGING SYSTEM (R2-ISS) IN A LARGE POPULATION-BASED, NATIONWIDE COHORT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

    P817: VALIDATION OF THE SECOND REVISED INTERNATIONAL STAGING SYSTEM (R2-ISS) IN A LARGE POPULATION-BASED, NATIONWIDE COHORT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA by Christian Brieghel, Morten Nørgaard Andersen, Nicolai Grønne Jørgensen, Trine Silkjær, Thomas Lund, Maja Hinge, Henrik Gregersen, Robert Schou Pedersen, Agoston Szabo, Carsten Niemann

    Published 2023-08-01
    Get full text
    Article
  2. 2
    Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models

    Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models by Jelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, Michael Roost Clausen, Ahmed Ludvigsen Al-Mashhadi, Robert Schou Pedersen, Christian Bjørn Poulsen, Peter Brown, Tarec Christoffer El-Galaly, Thomas Stauffer Larsen

    Published 2023-10-01
    Get full text
    Article
  3. 3
    P1676: RISK OF DEMENTIA IN OLDER PATIENTS TREATED WITH CHEMOTHERAPY FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY

    P1676: RISK OF DEMENTIA IN OLDER PATIENTS TREATED WITH CHEMOTHERAPY FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY by Eva Maksten, Lasse Jakobsen, Boris Modrau, Hilde Jensvoll, Kristian Hay Kragholm, Judit Jørgensen, Michael Roost Clausen, Robert Schou Pedersen, Andriette Dessau-Arp, Thomas Stauffer Larsen, Christian Bjorn Poulsen, Anne Ortved Gang, Peter Brown, Tarec El-Galaly, Marianne Severinsen

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.

    Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population. by Rasmus Sørrig, Tobias W Klausen, Morten Salomo, Annette J Vangsted, Ulf Christian Frølund, Kristian T Andersen, Anja Klostergaard, Carsten Helleberg, Robert S Pedersen, Per T Pedersen, Sissel Helm-Petersen, Elena Manuela Teodorescu, Birgitte Preiss, Niels Abildgaard, Peter Gimsing, Danish Myeloma Study Group

    Published 2017-01-01
    Get full text
    Article
  5. 5
    Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark

    Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark by Lasse Hjort Jakobsen, Andreas Kiesbye Øvlisen, Marianne Tang Severinsen, Joachim Bæch, Kristian Hay Kragholm, Ingrid Glimelius, Anne Ortved Gang, Judit Mészáros Jørgensen, Henrik Frederiksen, Christian Bjørn Poulsen, Michael Roost Clausen, Per Trøllund Pedersen, Robert Schou Pedersen, Christian Torp-Pedersen, Sandra Eloranta, Tarec Christoffer El-Galaly

    Published 2022-01-01
    Get full text
    Article
  6. 6
    P1610: VALIDATION AND CLINICAL CHARACTERISTICS OF THROMBOTIC THROMBOCYTOPENIC PURPURA AND EVANS SYNDROME DIAGNOSES IN NATIONWIDE DANISH HEALTH REGISTERS

    P1610: VALIDATION AND CLINICAL CHARACTERISTICS OF THROMBOTIC THROMBOCYTOPENIC PURPURA AND EVANS SYNDROME DIAGNOSES IN NATIONWIDE DANISH HEALTH REGISTERS by Dana Lawrie, Dennis Lund Hansen, Thomas Daell Leineweber, Sarah Birgitte Ingemod Sand Carlsen, Louise Hur Hannig, Per Trøllund Pedersen, Helene Bjørg Kristensen, Mads Okkels Birk Lorenzen, Jesper Stentoft, Peter Buur Van Kooten Niekerk, Maren Jørgensen, Marianne Severinsen, Mikkel Dorff, Robert Schou Pedersen, Andreas Glenthøj, Henrik Frederiksen

    Published 2023-08-01
    Get full text
    Article

Search Tools: